SCHEMBL6174769

SCHEMBL6174769

CC1(C(N)c2ccncc2C(=O)c2ccco2)NC(=O)N(c2ccc(SC(F)(F)F)cc2)C1=O

nearest known ligand 0.39

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 17/20 0.39
AR P10275 2/20 0.32
ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6173411 0.87 KMT2A (0.37) ARALDH1A1
SCHEMBL6175950 0.87 CA1 (0.35) IGF1RARALDH1A1
SCHEMBL6171845 0.82 IGF1R (0.46) IGF1RAR
SCHEMBL6171813 0.72 IGF1R (0.41) IGF1RARALDH1A1
SCHEMBL6172441 0.71 KMT2A (0.37) IGF1R
SCHEMBL6174315 0.71 IGF1R (0.41) IGF1RARALDH1A1
SCHEMBL6171681 0.71 IGF1R (0.43) IGF1R
SCHEMBL6172480 0.70 IGF1R (0.39) IGF1RARALDH1A1
SCHEMBL6173157 0.69 IGF1R (0.45) IGF1RARALDH1A1
SCHEMBL6172569 0.68 IGF1R (0.36) IGF1RALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed